105例注射用替加环素用药合理性分析
发布时间：2018-10-23 07:53
【摘要】：目的:加强替加环素使用的规范管理,评价其用药的合理性,为临床合理用药提供参考。方法:抽取我院2014年6月—2015年6月应用注射用替加环素(泰阁)的出院患者病例,从病原学检查、药物敏感性试验、用法用量、疾病类型等方面对105例病例进行评价分析。结果:我院应用注射用替加环素的药物利用指数(DUI)值为1.075;105例病例中,102(97.14%)例行病原学检查,76例(72.38%)有药敏试验结果;65例(61.90%)有2种以上混合感染;83例(79.05%)符合说明书给药剂量。结论:医疗机构需要对注射用替加环素的使用进行严格管理,并对其给药疗程、剂量及处方权限加以控制,防止经验性用药,减少耐药的发生。
[Abstract]:Objective: to strengthen the standardized management of the use of tegacycline, evaluate the rationality of its drug use, and provide reference for clinical rational use of tegacycline. Methods: 105 patients who were discharged with tegacycline (Taige) for injection from June 2014 to June 2015 were evaluated and analyzed in terms of etiological examination, drug sensitivity test, usage dosage, disease type and so on. Results: the drug utilization index (DUI) of tegicycline for injection in our hospital was 1.075% of 105 cases, 102.14% (97.14%) of them were pathologically examined, 76 cases (72.38%) had drug sensitivity test results, 65 cases (61.90%) had two or more mixed infections, 83 cases (79.05%) accorded with the prescribed dosage. Conclusion: medical institutions need to strictly manage the use of tegicycline for injection, and control the course, dosage and prescription authority of the administration of tegacyclin in order to prevent experiential drug use and reduce the occurrence of drug resistance.
【作者单位】： 解放军总医院第一附属医院药剂药理科;
【分类号】：R978.1
[Abstract]:Objective: to strengthen the standardized management of the use of tegacycline, evaluate the rationality of its drug use, and provide reference for clinical rational use of tegacycline. Methods: 105 patients who were discharged with tegacycline (Taige) for injection from June 2014 to June 2015 were evaluated and analyzed in terms of etiological examination, drug sensitivity test, usage dosage, disease type and so on. Results: the drug utilization index (DUI) of tegicycline for injection in our hospital was 1.075% of 105 cases, 102.14% (97.14%) of them were pathologically examined, 76 cases (72.38%) had drug sensitivity test results, 65 cases (61.90%) had two or more mixed infections, 83 cases (79.05%) accorded with the prescribed dosage. Conclusion: medical institutions need to strictly manage the use of tegicycline for injection, and control the course, dosage and prescription authority of the administration of tegacyclin in order to prevent experiential drug use and reduce the occurrence of drug resistance.
【作者单位】： 解放军总医院第一附属医院药剂药理科;
【分类号】：R978.1
【参考文献】
相关期刊论文 前8条
1 黄汉;郭鹏豪;陈怡丽;伍众文;廖康;;两种替加环素制剂对多重耐药细菌的体外抗菌活性比较[J];世界临床药物;2016年12期
2 张斌;陈明迪;郜琨;张玉红;任辉邦;;替加环素联合美罗培南治疗重症感染的疗效观察[J];现代药物与临床;2015年09期
3 高金丹;方强;苏群;;替加环素治疗多重或泛耐药鲍曼不动杆菌引起的重症肺炎的疗效评价[J];中国抗生素杂志;2015年08期
4 周洋;黄河;张家洪;;替加环素联合头孢哌酮舒巴坦治疗多重耐药鲍曼不动杆菌肺炎的疗效观察[J];实用医学杂志;2015年05期
5 孙桂凤;陈，
本文编号：2288580
本文链接：https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2288580.html
最近更新
教材专著
